RESEARCH TRIANGLE PARK, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. NASDAQ:BCRX today announced that the compensation committee of BioCryst’s board of directors granted nine newly-hired employees stock options to purchase an aggregate of 33,950 shares, and restricted stoc…
Encinitas, California--(Newsfile Corp. - July 2, 2026) - Kiora Pharmaceuticals, Inc. NASDAQ:KPRX today announced that it will participate in an investor fireside chat at the Piper Sandler Virtual Ophthalmology Symposium.Presentation DetailsDate: Thursday, July 9, 2026Time: 2:30 p.m. Eastern Dayligh…
Calgary, Alberta--(Newsfile Corp. - July 2, 2026) - OBSIDIAN ENERGY LTD. TSX:OBE (NYSE American: OBE) ("Obsidian Energy", the "Company", "we", "us" or "our") has closed our previously announced acquisition of Belly River light oil assets in the Wilson Creek area of Willesden Green (the "Acquisition…
Abstract recently submitted in anticipation of initial data analysis ahead of ESCCompany expects to report topline LEVEL results in AugustCHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. NASDAQ:TENX (“Tenax” or “Tenax Therapeutics” or the “Company”) announced today that…
VERAXA Biotech Initiates Cell Line Development With ATUM to Advance Its Lead BiTAC-TCE Program
ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activitiesZURICH, SWITZERLAND – July 02, 2026 -- VERAXA Biotech AG NASDAQ:VRXA; “VERAXA”), an emerging leader in designi…
MINNEAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. CSE:VREO OTCQX:VREOF (“Vireo” or the “Company”), a leading vertically integrated cannabis company and agricultural markets platform today announced that it has entered into a Securities Purchase Agreement ("SPA") to acquire, jointly w…
Exelixis Price Target Maintained With a $56.00/Share by HC Wainwright & Co.
By Adam ClarkJust a day after a report emerged that Meta Platforms wants to build a cloud business to sell excess artificial-intelligence computing power, Japan's SoftBank has announced it is piling into the space.Meta stock got a significant one day boost after the report — which is yet to be conf…
By Kelly CloonanUnited Therapeutics acquired privately-held biotechnology company Thymmune Therapeutics for $140 million in cash.The deal could include potential earn-out payments to former Thymmune equityholders of up to $160 million based on the achievement of certain clinical and regulatory mile…
The Greenbrier Companies, Inc. GBX used its third-quarter fiscal 2026 earnings call to reinforce a message of resilience rather than rapid recovery. Management emphasized that operational improvements, disciplined cost control, and an expanding leasing platform are helping the company navigate one…
(10:56 GMT) Amazon Price Target Raised to $313.00/Share From $312.00 by Wells Fargo
(10:55 GMT) Alphabet Price Target Cut to $416.00/Share From $435.00 by Wells Fargo
(10:54 GMT) General Mills Price Target Raised to $33.00/Share From $30.00 by Wells Fargo
Take-Two Interactive Price Target Maintained With a $293.00/Share by BTIG
Lindsay reported third-quarter fiscal 2026 results with revenues of $160.8 million and net earnings of $15.8 million, or $1.53 diluted earnings per share. Operating income for the quarter was $18.5 million and gross profit was $47.8 million. The company completed $25.2 million of share repurchases…
(10:51 GMT) FactSet Research Price Target Raised to $210.00/Share From $200.00 by Wells Fargo
(10:51 GMT) Meta Platforms Price Target Raised to $767.00/Share From $765.00 by Wells Fargo
(10:50 GMT) Eversource Energy Price Target Raised to $76.00/Share From $75.00 by Wells Fargo
RNS Number : 8009K Barclays PLC 02 July 2026 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distri…
